You are here

Study Comparing the Efficacy of Venlafaxine XR Vs. SSRIs and Conventional Antidepressants in Depressed Patients

Last updated on February 23, 2019

FOR MORE INFORMATION
Study Location
Beijing, Beijing, 100080 China
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Major Depressive Disorder
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18-65 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Males or females, 18 -65 years of age

- Outpatients

- Major depressive disorder based on DSM-IV criteria

- The baseline score of 17-item HAM-D³17

- Switchers from prior antidepressants, who have had no satisfactory improvement
(normally after a minimum of 8weeks of treatment), with an approved antidepressant
medication or have experienced intolerance due to side effects to their antidepressant
medication based on clinical discretion

- Provide written informed consent

- If female is of childbearing potential, must be confirmed no pregnancy at baseline,
and use a medically acceptable method of contraception throughout the study.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Hypersensitivity to venlafaxine;

- Clinically significant renal or hepatic disease or any other medical disease that, in
the opinion of the investigator, might compromise the study, including seizure

- Alcohol or drug abuse within the last year

- A recent history of myocardial infarction or unstable heart disease (within 6 months
of baseline)

- Bipolar disorder

- For female, known or suspected pregnancy or breast feeding

- Use of a monoamine oxidase inhibitor (MAOI) within 14 days of baseline; use of any
investigational drug within 30 days of baseline.

- Patients have prior use of venlafaxine or use of venlafaxine for the current episode.

NCT00474708
Pfizer
Completed
Study Comparing the Efficacy of Venlafaxine XR Vs. SSRIs and Conventional Antidepressants in Depressed Patients

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now